REIT - Mortgage
Compare Stocks
2 / 10Stock Comparison
AOMR vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
AOMR vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Mortgage | REIT - Healthcare Facilities |
| Market Cap | $220M | $149.25B |
| Revenue (TTM) | $104M | $11.63B |
| Net Income (TTM) | $16M | $1.43B |
| Gross Margin | 67.7% | 39.1% |
| Operating Margin | 43.7% | 4.4% |
| Forward P/E | 6.8x | 78.4x |
| Total Debt | $308M | $21.38B |
| Cash & Equiv. | $42M | $5.03B |
AOMR vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 21 | May 26 | Return |
|---|---|---|---|
| Angel Oak Mortgage,… (AOMR) | 100 | 49.4 | -50.6% |
| Welltower Inc. (WELL) | 100 | 256.3 | +156.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AOMR vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AOMR carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 158.1%, EPS growth 53.8%
- 158.1% FFO/revenue growth vs WELL's 35.8%
- Lower P/E (6.8x vs 78.4x)
WELL is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 0.13, yield 1.3%
- 223.1% 10Y total return vs AOMR's -18.8%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 158.1% FFO/revenue growth vs WELL's 35.8% | |
| Value | Lower P/E (6.8x vs 78.4x) | |
| Quality / Margins | 15.6% margin vs WELL's 12.3% | |
| Stability / Safety | Beta 0.13 vs AOMR's 0.67, lower leverage | |
| Dividends | 14.4% yield, vs WELL's 1.3% | |
| Momentum (1Y) | +42.7% vs AOMR's +3.9% | |
| Efficiency (ROA) | 2.3% ROA vs AOMR's 0.6%, ROIC 0.5% vs 8.8% |
AOMR vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AOMR vs WELL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — AOMR and WELL each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 112.3x AOMR's $104M. Profitability is closely matched — net margins range from 15.6% (AOMR) to 12.3% (WELL). On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $104M | $11.6B |
| EBITDAEarnings before interest/tax | $45M | $2.8B |
| Net IncomeAfter-tax profit | $16M | $1.4B |
| Free Cash FlowCash after capex | -$136M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +67.7% | +39.1% |
| Operating MarginEBIT ÷ Revenue | +43.7% | +4.4% |
| Net MarginNet income ÷ Revenue | +15.6% | +12.3% |
| FCF MarginFCF ÷ Revenue | -131.8% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -18.0% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -134.5% | +22.5% |
Valuation Metrics
AOMR leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 4.9x trailing earnings, AOMR trades at a 97% valuation discount to WELL's 153.3x P/E. On an enterprise value basis, AOMR's 3.3x EV/EBITDA is more attractive than WELL's 66.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $220M | $149.2B |
| Enterprise ValueMkt cap + debt − cash | $486M | $165.6B |
| Trailing P/EPrice ÷ TTM EPS | 4.91x | 153.25x |
| Forward P/EPrice ÷ next-FY EPS est. | 6.76x | 78.42x |
| PEG RatioP/E ÷ EPS growth rate | 0.04x | — |
| EV / EBITDAEnterprise value multiple | 3.30x | 66.40x |
| Price / SalesMarket cap ÷ Revenue | 1.66x | 13.99x |
| Price / BookPrice ÷ Book value/share | 0.80x | 3.35x |
| Price / FCFMarket cap ÷ FCF | 11.84x | 52.41x |
Profitability & Efficiency
AOMR leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
AOMR delivers a 6.2% return on equity — every $100 of shareholder capital generates $6 in annual profit, vs $3 for WELL. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to AOMR's 1.15x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +6.2% | +3.5% |
| ROA (TTM)Return on assets | +0.6% | +2.3% |
| ROICReturn on invested capital | +8.8% | +0.5% |
| ROCEReturn on capital employed | +6.7% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 |
| Debt / EquityFinancial leverage | 1.15x | 0.49x |
| Net DebtTotal debt minus cash | $266M | $16.3B |
| Cash & Equiv.Liquid assets | $42M | $5.0B |
| Total DebtShort + long-term debt | $308M | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | 1.43x | 0.26x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $8,118 for AOMR. Over the past 12 months, WELL leads with a +42.7% total return vs AOMR's +3.9%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs AOMR's 17.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +6.5% | +14.3% |
| 1-Year ReturnPast 12 months | +3.9% | +42.7% |
| 3-Year ReturnCumulative with dividends | +60.6% | +189.5% |
| 5-Year ReturnCumulative with dividends | -18.8% | +202.3% |
| 10-Year ReturnCumulative with dividends | -18.8% | +223.1% |
| CAGR (3Y)Annualised 3-year return | +17.1% | +42.5% |
Risk & Volatility
WELL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than AOMR's 0.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 97.0% from its 52-week high vs AOMR's 85.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.67x | 0.13x |
| 52-Week HighHighest price in past year | $10.34 | $219.59 |
| 52-Week LowLowest price in past year | $7.96 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +85.4% | +97.0% |
| RSI (14)Momentum oscillator 0–100 | 50.6 | 60.2 |
| Avg Volume (50D)Average daily shares traded | 71K | 2.6M |
Analyst Outlook
Evenly matched — AOMR and WELL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates AOMR as "Buy" and WELL as "Buy". Consensus price targets imply 10.4% upside for AOMR (target: $10) vs 6.3% for WELL (target: $227). For income investors, AOMR offers the higher dividend yield at 14.41% vs WELL's 1.30%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $9.75 | $226.50 |
| # AnalystsCovering analysts | 7 | 34 |
| Dividend YieldAnnual dividend ÷ price | +14.4% | +1.3% |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | $1.27 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
AOMR leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). WELL leads in 2 (Total Returns, Risk & Volatility). 2 tied.
AOMR vs WELL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is AOMR or WELL a better buy right now?
For growth investors, Angel Oak Mortgage, Inc.
(AOMR) is the stronger pick with 158. 1% revenue growth year-over-year, versus 35. 8% for Welltower Inc. (WELL). Angel Oak Mortgage, Inc. (AOMR) offers the better valuation at 4. 9x trailing P/E (6. 8x forward), making it the more compelling value choice. Analysts rate Angel Oak Mortgage, Inc. (AOMR) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AOMR or WELL?
On trailing P/E, Angel Oak Mortgage, Inc.
(AOMR) is the cheapest at 4. 9x versus Welltower Inc. at 153. 3x. On forward P/E, Angel Oak Mortgage, Inc. is actually cheaper at 6. 8x.
03Which is the better long-term investment — AOMR or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -18. 8% for Angel Oak Mortgage, Inc. (AOMR). Over 10 years, the gap is even starker: WELL returned +223. 1% versus AOMR's -18. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AOMR or WELL?
By beta (market sensitivity over 5 years), Welltower Inc.
(WELL) is the lower-risk stock at 0. 13β versus Angel Oak Mortgage, Inc. 's 0. 67β — meaning AOMR is approximately 407% more volatile than WELL relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 115% for Angel Oak Mortgage, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AOMR or WELL?
By revenue growth (latest reported year), Angel Oak Mortgage, Inc.
(AOMR) is pulling ahead at 158. 1% versus 35. 8% for Welltower Inc. (WELL). On earnings-per-share growth, the picture is similar: Angel Oak Mortgage, Inc. grew EPS 53. 8% year-over-year, compared to -11. 5% for Welltower Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AOMR or WELL?
Angel Oak Mortgage, Inc.
(AOMR) is the more profitable company, earning 33. 2% net margin versus 8. 8% for Welltower Inc. — meaning it keeps 33. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AOMR leads at 110. 8% versus 3. 3% for WELL. At the gross margin level — before operating expenses — AOMR leads at 90. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AOMR or WELL more undervalued right now?
On forward earnings alone, Angel Oak Mortgage, Inc.
(AOMR) trades at 6. 8x forward P/E versus 78. 4x for Welltower Inc. — 71. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AOMR: 10. 4% to $9. 75.
08Which pays a better dividend — AOMR or WELL?
All stocks in this comparison pay dividends.
Angel Oak Mortgage, Inc. (AOMR) offers the highest yield at 14. 4%, versus 1. 3% for Welltower Inc. (WELL).
09Is AOMR or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +223. 1% 10Y return). Both have compounded well over 10 years (WELL: +223. 1%, AOMR: -18. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AOMR and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.